## Deliverables (DL) in Lot 2- EQA for STEC 

DL1: A letter of invitation to participate in the EQA scheme within one month after the agreed start of the EQA. The letter should include information about the EQA timetable, methods to be used and how the results will be reported. 

DL2: A list of laboratories  of participants that signed up to take part of the EQA scheme. ECDC has the right to review the list of invited/participating laboratories and make changes where needed. The list should be provided within two months after the agreed start of the EQA. 

DL3: A detailed project plan  for the full EQA exercise with tasks, timelines, methods to be used and an overview of the bacterial strains and sequences to be included in the EQA and the rationale for selecting them. The plan with detailed project schedule should be approved by ECDC before execution. Preparation and distribution of test strains/sequences should be done within 4 months after the agreed start of the EQA. 

DL4: Individual evaluation reports  about the performance of each participating laboratory on each method to allow the participant to rate their performance against the expected results. The feedback reports must include recommendations for improvements and troubleshooting advice (if needed), and should be provided within two months after collecting the results from participating laboratories. Copies of the individual evaluation reports should be provided to ECDC. 

DL5: ECDC certificates provided to the participating laboratories within two months after collecting the EQA results using the ECDC template and following approval by ECDC. 

DL6: A participant feedback survey administered within 2 to 4 weeks after collecting the results from participating laboratories. The results must be provided to ECDC and aggregated results included and discussed in the comprehensive EQA report (DL 7). 

DL7:  The collated raw data of the EQA exercise (information and results from participating laboratories) in an electronic database . This data should be provided to ECDC within six months after collecting the results from participating laboratories. 

DL8: A comprehensive EQA report per EQA scheme and per pathogen on the outcomes of the EQA exercise using ECDC’s template. This report should identify common problems (if any) and discuss potential reasons for any diverging results, putting the results in the overall context and make recommendations for improving the laboratory performance at the EU-level. The report should summarise the results of the participating laboratories and provide pseudonymous individual data. The report should be provided to ECDC within six months after collecting the results from participating laboratories. The report will be published on ECDC website after internal clearance. 

DL9: A PowerPoint presentation summarising the EQA results in a clear and concise way with graphics that aid in the interpretation of the results provided to ECDC within six months after collecting the results from participating laboratories. 

DL10 : A final report at the completion of the EQA summarising up all the activities during a specific contract period including information about shipment of test strains, problems encountered, performance and trouble-shooting services provided to the participating laboratories not able to achieve acceptable level of performance. 

Time frame: The entire scheme will be a maximum of 12 months. 

